omalizumab

Weekly Aspergillosis Research Update – 5 October 2026

This week’s research includes…

Developments in Biologic and Inhaled Antifungal medications for ABPA

Updated October 2026…

Kay A: living with ABPA, asthma and a mycobacterial infection

Kay shared this account…

Joan B: her experience taking Xolair

Joan shared this account…

Illustration showing how Xolair (omalizumab) treats allergic bronchopulmonary aspergillosis (ABPA) by blocking IgE antibodies and reducing allergic inflammation in the lungs.

Why Can an Asthma Drug Help ABPA? Understanding Xolair (Omalizumab)

🌿 Biologics when ABPA and CPA overlap: What Patients Need to Know

Understanding how they work,…

🌿 ABPA: Infection, Allergy, Biologics, and What It All Means for You

A calm, supportive guide for…

Omalizumab: how does it help relieve ABPA?

Omalizumab (Xolair) is a…